the use of adjuvant therapy in elderly patients with resected non-small cell lung cancer (nsclc)
Published 5 months ago • 1 view plays • Length 7:30Download video MP4
Download video MP3
Similar videos
-
50:38
adjuvant egfr tki therapy in patients with completely resected non-small-cell lung cancer: curren...
-
6:20
asco 2023 highlights on adjuvant osimertinib in resected egfr mutated nsclc: the adaura trial
-
3:30
adaura: osimertinib adjuvant therapy on cns disease recurrence
-
8:20
impower010: atezolizumab versus best supportive care after adjuvant chemotherapy in resected nsclc
-
20:16
adjuvant therapy in nsclc: is there any hope beyond chemotherapy?
-
23:42
current status of adjuvant therapy for nsclc
-
2:20
adjuvant osimertinib in resected egfrm nsclc: the os data from the adaura trial
-
2:33
adaura: osimertinib adjuvant therapy in egfr mutated nsclc
-
10:45
debate: adjuvant egfr-directed therapy for patients with early stage nsclc? - no
-
8:44
adjuvant egfr inhibition in patients with nsclc
-
13:56
adjuvant therapy - chemotherapy issues
-
32:51
adjuvant therapy for early stage lung cancer – case based discussion for patient with stage 1b nsclc
-
14:39
debate: adjuvant therapy for resected node negative stage i nsclc? - sometimes
-
14:59
gracecast-074_lung-cancer_ccilc - adjuvant therapy for smaller node-negative nsclc
-
5:03
adaura results: adjuvant osimertinib for egfrm non-small cell lung cancer
-
3:02
neoadjuvant and adjuvant immunotherapy in non-small cell lung cancer
-
15:28
adjuvant systemic therapy and adjuvant radiation therapy for stage i to iiia completely resected ...
-
16:41
asco lung cancer roundtable - trial updates in nsclc - adaura trial and post surgery egfr mutation
-
4:50
impower010: adjuvant atezolizumab improves dfs in resected stage ii-iiia nsclc